Information for: Alumni Prospective Students Current Students

Population Aging Research Center

Home
About Us
People
Research
Working Papers
Newsletters
Services
News & Events
Pilot Awards
- Pilot Awards
- Quartet Pilot Project Competition
Training
Allied Centers

NIH Funding Opportunities (Notices, PA, RFA)

Methamphetamine overdose deaths rise sharply nationwide
NIH researchers identify new genetic disorder that affects brain, craniofacial skeleton
NIH study compares low-fat, plant-based diet to low-carb, animal-based diet
Updated Guidelines for Enhancing Diversity and Creating Safe Environments in Conferences Supported by NIH Grants and Cooperative Agreements
Notice of Special Interest (NOSI): Promoting Research on Interoception and Its Impact on Health and Disease
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32)
Notice of Information Regarding NIGMS Changes to Candidate and Activity Code Eligibility for PA-21-071 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
Enhancing Diversity at NIH-Funded Conferences
Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients
On Fox News at Night with Shannon Bream, Dr. Collins discusses the U.S. COVID-19 vaccine rollout plan and vaccine prioritization
Dr. Collins speaks to MSNBC’s Ali Velshi about emerging COVID-19 variants and the U.S. vaccine supply
Notice of Termination of RFA-TR-20-030 "Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
Notice of Change to Key Dates for Cellular Senescence Network (SenNet) RFA-RM-21-008 "Cellular Senescence Network: Tissue Mapping Centers (U54 Clinical Trial Not Allowed)"
Notice of Change to Key Dates for RFA-RM-21-009 "Cellular Senescence Network: Technology Development and Application (UG3/UH3 Clinical Trial Not Allowed)"
NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed)
Notice of Change to Key Dates for RFA-RM-21-010 "Cellular Senescence Network: Consortium Organization and Data Coordinating Center (U24 Clinical Trial Not Allowed)"
Notice of Pre-Application Information Webinar and Frequently Asked Questions (FAQs) for RFA-DA-21-020, RFA-DA-21-021, RFA-DA-21-022, and RFA-DA-21-023
Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers
Notice of Pre-Application Webinar for the Common Funds Nutrition for Precision Health Program RFAs.
Low-dose aspirin may improve pregnancy chances for women with one or two prior miscarriages
Physician-pharmacist collaboration may improve care for opioid addiction
Acute heart transplant rejection detected earlier with new test
Lasting immunity found after recovery from COVID-19
<a href="/news-events/nih-research-matters/physician-pharmacist-collaboration-may-improve-care-opioid-addiction">Physician-pharmacist collaboration may improve care for opioid addiction</a>
NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed)
Notice of NIDA's Participation in NOT- MD-21-008 "Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities"
Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection
Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)
Notice of Special Interest (NOSI): NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)
Antibody infusions prevent acquisition of some HIV strains, NIH studies find
NIH launches database to track neurological symptoms associated with COVID-19
Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes
Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2021
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trials Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trials Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trials Not Allowed)
Notice of Special Interest (NOSI): High-Priority Interest to Enhance Data Science Research Training in Addiction Research
Dr. Collins participates in The Hill’s COVID-19 Vaccine Virtual Live Event
On the Track the Vax podcast, Dr. Collins provides an update on COVID-19 therapeutics and the vaccine rollout plan
February 15 (Monday), 2021: NIH Closed for the Federal Holiday
How Do I Submit Preliminary Data as Post-Submission Material Under the Special Exception During the COVID-19 Pandemic?
Writing An Effective “K” Application: A Video Guide
Study links neighborhood conditions to adolescent sleep loss
Researchers use patients’ cells to test gene therapy for rare eye disease
Severe COVID-19 in pregnancy associated with preterm birth, other complications
Notice of Clarification of Award Budget for RFA-HD-21-023, NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional)
The Cellular Scale Connectome in Aging and Alzheimers Disease (U01 Clinical Trial Not Allowed)
Notice of Intent to Publish Funding Opportunity Announcements for Research on Firearm Injury and Mortality Prevention
Notice of Legislative Mandates in Effect for FY 2021
Notice of Fiscal Policies in Effect for FY 2021
Guidance on Salary Limitation for Grants and Cooperative Agreements FY 2021
Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U54)
Notice of NIAID's Participation in PAR-19-040: Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
Notice of NIAID's Participation in PAR-20-253: Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)
Notice of NIAID's Participation in PAR-20-316: NIH Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 - Clinical Trial Optional)
Notice of NIAID's Participation in PAR-19-039: Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
Notice of Change to RFA-DA-21-016, "Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R43/R44 - Clinical Trials Optional)"
Janssen Investigational COVID-19 Vaccine: Interim Analysis of Phase 3 Clinical Data Released
Scientists identify locations of early prion protein deposition in retina
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required)
Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)
Notice of Change to Key Dates of PAR-20-286, "Practice-Based Suicide Prevention Research Centers (P50 Clinical Trial Optional)"
Request for Information on the 2021-2026 National Institute of Neurological Disorders and Stroke Strategic Plan
Notice of Correction to PAR-20-256: Clarification on Frequency of Usage Reports
Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional)
Limited Competition for the Continuation of Multisite Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Optional)
NIH R01 Grant Outcomes of T32 Postdoctoral Participants: Associations with Demographics, Cohort, Degree, and Career Development (K) Awards
NIH study shows hyaluronan is effective in treating chronic lung disease
Office of Laboratory Animal Welfare Webinar – 21st Century Cures Act: Update on Implementation
NIH networks to advance emotional well-being research
<a href="/news-events/nih-research-matters/study-examines-measures-slow-covid-19-spread">Study examines measures to slow COVID-19 spread</a>
<a href="/news-events/nih-research-matters/gut-bacteria-use-nutrient-fight-germs">Gut bacteria use nutrient to fight off germs</a>
<a href="/news-events/nih-research-matters/brown-fat-associated-less-heart-metabolic-disease">Brown fat associated with less heart and metabolic disease</a>
Brown fat associated with less heart and metabolic disease
Study examines measures to slow COVID-19 spread
Gut bacteria use nutrient to fight off germs
Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Human Milk as a Biological System (R01 Clinical Trial Optional)
Reminder Requesting Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19
Notice of Change to Key Dates for PA-18-622 "Disease Mechanisms of Prenatal and Pediatric Hydrocephalus (R01 Clinical Trial Not Allowed)"
Notice of Change to Key Dates for PA-18-623 "Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus (R21 Clinical Trial Not Allowed)"
Friendlier Format for Key Dates in Funding Opportunities
FY 2021 Fiscal Policies for Grant Awards: Funding Levels, Salary Limits, and Stipend Levels
Request for Information (RFI): Screening for High Resolution Cryo-Electron Microscopy
Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
Notice of Special Interest (NOSI): Administrative Supplement Opportunity to Study the Impact of COVID-19 on Global Cancer Prevention and Control
Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders
Request for Information (RFI): Use of Common Data Elements (CDEs) in NIH-funded research
Screening for Conditions by Electronic Nose Technology (SCENT) (U01 Clinical Trial Optional)
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
Notice to Extend the Expiration Date for PAR-19-222, "Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)"
Early-Phase Clinical Trials of Novel Interventions to Prevent, Delay, or Treat Aging-Related Conditions by Targeting Aging-Related Mechanisms (U01 Clinical Trial Required)
Intranasal influenza vaccine spurs strong immune response in Phase 1 study
Computerized adaptive screener may help identify youth at risk for suicide
High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed)
Notice to Extend the Expiration Date for PA-18-590 Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
UPDATE Implementation of Requirement to Submit the Federal Financial Report (FFR) in the Payment Management System
Notice of Special Interest (NOSI): Urgent Competitive Revisions and Administrative Supplements for Research at NIMHD Research Centers in Minority Institutions (RCMI U54s) on SARS-CoV-2 Vaccine Hesitancy, Uptake, and Implementation
Notice of Special Interest (NOSI): Complement in Basic Immunology (CIBI)
Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19
Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations with the NCI-supported Drug Resistance and Sensitivity Network (DRSN)
For a profile on Dr. Collins, TIME magazine highlights his accomplishments leading the NIH under three presidents, emphasizing his contributions to the COVID-19 pandemic response, and his ability to bridge the gap between science and faith
Fecal microbiota transplants help patients with advanced melanoma respond to immunotherapy
Notice of Expiration - PA-21-158, "Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33) - Clinical Trial Optional"
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)
SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)
NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed)
Help Us Understand How You Use Common Data Elements in NIH-Supported Research
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
Notice of Special Interest: Availability of Administrative Supplements to INBRE Awards to Fund Research Collaborations
Notice of Changes in the Review Criteria for Applications Submitted for NIH Support for Scientific Conferences (R13 and U13)
Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)
Notice of Change to Eligibility of Foreign Components and Requirement for Letter of Support for PAR-21-109, "Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
Notice of Extension PA-17-008
Notice of Intent to Publish a Funding Opportunity Announcement for Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed)
Human Immunology Project Consortium (U19 Clinical Trial Optional)
Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)
Extensions for Early Career Scientists Whose Career Trajectories Have Been Significantly Impacted by COVID-19
Clinical trial in hospitalized COVID-19 patients evaluates long-acting antibody therapy
Distinctness of mental disorders traced to differences in gene readouts
Experimental treatment helps patients hospitalized with COPD
<a href="/news-events/nih-research-matters/low-fat-diet-compared-low-carb-diet">Low-fat diet compared to low-carb diet</a>
<a href="/news-events/nih-research-matters/combination-therapy-methamphetamine-use-disorder">Combination therapy for methamphetamine use disorder</a>
Low-fat diet compared to low-carb diet
<a href="/news-events/nih-research-matters/experimental-treatment-helps-patients-hospitalized-copd">Experimental treatment helps patients hospitalized with COPD</a>
Combination therapy for methamphetamine use disorder
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional)
Notice of Special Interest (NOSI): Availability of Administrative Supplements for BRAIN Initiative Awardees to Support Resource Dissemination
Request for Information (RFI): Inviting Comments on the NCCIH Strategic Plan for Fiscal Years 2021-2025
Notice of Intent to Publish a Funding Opportunity Announcement for Specialized Alcohol Research Centers (P50 Clinical Trial Optional)
Findings of Research Misconduct
NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
Underground Mine Evacuation Technologies and Human Factors Research (U60)
Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders
Notice of Early Expiration of NOT-MD-20-011 Notice of Special Interest: Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)
NIH’s TOPMed program publishes data on over 53,000 diverse genomes
NIH calls for greater inclusion of pregnant and lactating people in COVID-19 vaccine research
Notice of Special Interest (NOSI): Availability of Administrative Supplements for Submission of Tissue Chip Data to the Microphysiology Systems Database (MPS-Db)
Notice of Change to Key Dates for PA-21-110, "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)"
Notice of Intent to Publish a Funding Opportunity Announcement for Autism Centers of Excellence: Networks (R01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Autism Centers of Excellence: Centers (P50 Clinical Trial Optional)
Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Required)
Notice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research
Policy on Protecting Life in Global Health Assistance is Revoked
Notice of Pre-Application Webinar for RFA-TR-21-008, Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Optional)
Basic Research to Inform Vaccine and Therapeutic Development for Non-Polio Human Enteroviruses (NPEV) (R01 Clinical Trial Not Allowed)
Four potential COVID-19 therapeutics enter Phase 2/3 testing in NIH ACTIV-2 trial
NIH experts discuss SARS-CoV-2 viral variants
Study Identifies Risk Factors for Elevated Anxiety in Young Adults During COVID-19 Pandemic
Researchers propose that humidity from masks may lessen severity of COVID-19
Notice of Special Interest (NOSI): Hearing Healthcare for Adults: Improving Access and Affordability
Progress Towards a Modernized ClinicalTrials.gov
Keeping on Top of NIH-Funded Research You Care the Most About Just Got Easier
Notice of Early Expiration for PAR-19-337 "Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional)"
Combination treatment for common glioma type shows promise in mice
Genetic study of Lewy body dementia supports ties to Alzheimer’s and Parkinson’s diseases
Tobacco Regulatory Science (R01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics]
Fogarty Global Trauma and Injury Research Training Program (D43 Clinical Trial Optional)
Notice of Early Expiration of NOT-AI-20-065 Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Notice of Special Interest (NOSI): Translation of Quantitative Imaging tools and Methods for the Academic Industrial Partnership
NIH funds study to evaluate remdesivir for COVID-19 in pregnancy
Notice of Change to Key Dates for PAR-21-115 "Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)"
Notice of Change to Key Dates in RFA-CA-21-001, "Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)"
Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34 - Clinical Trial Not Allowed)
Notice of NIDDK Participation in PAR-19-274, "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)"
Notice of NIBIB Participation in PA-20-183, "Research Project Grant (Parent R01 Clinical Trial Required)"
Notice of NIBIB Participation in PA-20-262, "PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"
NIBIB Guidance for Support of Clinical Trial Applications
Notice of NIBIB Participation in PA-20-261, "PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)"
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies
Notice Announcing the National Human Genome Research Institutes Expectation for Sharing Quality Metadata and Phenotypic Data
Reminder: NIH Natural Disaster Policy Winter Storms
Limited Competition: Facility and Building System Upgrades Support for the Regional Biocontainment Laboratories (G20 Clinical Trial Not Allowed)
Innovation for Tuberculosis Vaccine Discovery (ITVD) (R61/R33 Clinical Trial Not Allowed)
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Research Grants for the Metabolic Dysregulation and Cancer Risk Program: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: a Transdisciplinary Approach to Obesity-associated Research (U01 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): National Research Service Award (NRSA) F32 Postdoctoral Fellowship Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities
Request for Information (RFI): Leveraging Clinical Trial Populations in NCIs National Clinical Trial Network (NCTN) and Community Oncology Research Program (NCORP) for Observational Cancer Survivorship Studies
Immune Cell Engineering For Targeted Therapy And Disease Monitoring in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
To end HIV epidemic, we must address health disparities
Video coaching program may improve parenting skills and children’s school readiness
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required)
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required)
Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health
Changes in the Review Criteria for Applications Submitted for NIH Support for Scientific Conferences (R13 and U13)
All About Grants Podcast: Considerations for a Research Plan
Computerized screening may help identify youth at risk for suicide
Humidity from masks may lessen severity of COVID-19
Engineered cartilage produces anti-inflammatory drug
<a href="/news-events/nih-research-matters/engineered-cartilage-produces-anti-inflammatory-drug">Engineered cartilage produces anti-inflammatory drug</a>
<a href="/news-events/nih-research-matters/humidity-masks-may-lessen-severity-covid-19">Humidity from masks may lessen severity of COVID-19</a>
<a href="/news-events/nih-research-matters/computerized-screening-may-help-identify-youth-risk-suicide">Computerized screening may help identify youth at risk for suicide </a>
Notice of Pre-Application Webinar for Gabriella Miller Kids First Pediatric Research Program RFA-RM-21-011: Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Modules to Promote Safe and Inclusive Biomedical Research Training Environments
Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Activities to Enhance Wellness and Resiliency in the Training Environment
Notice of NICHD Participation in RFA-DA-21-023 "HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24)"
Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional)
Maximizing Access to Research Careers (T34 - Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Black Children and Adolescents (R01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Black Children and Adolescents (R34 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional)
Notice of NICHD Participation in RFA-DA-21-020 "HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed)"
Notice of NICHD Participation in RFA-DA-21-021 "HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed)"
Notice of NICHD Participation in RFA-DA-21-022 "HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed)"
Notice of Intent to Publish a Funding Opportunity Announcement for NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award
Mouse study shows bacteriophage therapy could fight drug-resistant Klebsiella pneumoniae
Ever Wondered What Happens During the Scientific Review of an NIH Grant Application?
Monoclonal antibodies against MERS coronavirus show promise in Phase 1 NIH-sponsored trial
NIH launches new initiative to study “Long COVID”
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed)
Notice of Expiration of RFA-RM-20-023 "NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed)"
Notice of National Institute on Alcohol Abuse and Alcoholism (NIAAA) Participation in PAR-21-144, Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 BESH Required)"
Notice of NEI Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
Notice of National Institute on Alcohol Abuse and Alcoholism (NIAAA) Participation in PAR-21-145, Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed)
NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed)
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
Notice of Change to Participation for RFA-MH-20-620, "BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)"
Reminder: Switch Early to the New Secure Two-Factor Authentication Required to Access eRA Modules
Dr. Collins stresses the importance of maintaining public health measures with Fox Business’ Neil Cavuto
NIH study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
New experiences enhance learning by resetting key brain circuit
Notice of Special Interest (NOSI): Administrative Supplements for Equipment Purchases for NIGMS-funded Center and Core Facilities
Notice of Change to Award Information in PAR-20-108, "International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
Notice of Information: Submission of NIAID Investigator-Initiated Clinical Trials to Appropriate FOAs
Request for Proposals (RFP) Notice: Development and Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorders
Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases and Sjogrens Syndrome (UC2 Clinical T
Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2) (Clinical Trials Not Allowed)
Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed)
Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Notice of Special Interest (NOSI): NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional)
Notice of Special Interest (NOSI): Administrative Supplements to STTR Regional Technology Transfer Accelerator Hubs to Provide Instruction in Business Fundamentals to Core Facility Directors
Notice of Special Interest (NOSI): Administrative Supplements to Enhance Program Evaluation Capacity
Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Activities to Enhance Mentoring in the Research Training Environment
The Midlife in the United States Study - Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed)
The Midlife in the United States Study (U19 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
Notice of Special Interest (NOSI): Using Data to Advance HIV Epidemic Knowledge and Program Planning
Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration
Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Modules to Enhance Undergraduate Biomedical Research Training
Notice of Special Interest (NOSI): Administrative Supplements for Equipment Purchases for NIGMS R01, R35, and R37 Awardees
Notice of Special Interest (NOSI): Administrative Supplements to Enhance Laboratory Safety Curriculum and a Culture of Safety in Biomedical Research Training Environments
Notice of Special Interest (NOSI): Administrative Supplements to Support Undergraduate Summer Research Experiences
Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional)
Study identifies cardiovascular risk factors that may lead to pregnancy problems for first-time moms
Dr. Collins speaks to Associated Press’ Lauran Neergaard about the J&J single-dose COVID-19 vaccine
Dr. Collins speaks to Associated Press’ Lauran Neergaard about the J&J single-dose COVID-19 vaccine
Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine
Notice of Change to Key Dates for PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs to Address SARS-CoV-2 Vaccine Hesitancy
Request for Information (RFI): Inviting Comments and Suggestions to Advance and Strengthen Racial Equity, Diversity, and Inclusion in the Biomedical Research Workforce and Advance Health Disparities and Health Equity Research
Notice Announcing NHGRI Guidance for Third-Party Involvement in Extramural Research
Announcement of Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows
Notice of Special Interest (NOSI): Availability of Administrative Supplements for Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows
NIH Stands Against Structural Racism in Biomedical Research
NIH stands against structural racism in biomedical research
NIH to evaluate COVID-19 at-home testing system
Dr. Collins speaks to NBC News’ Stephanie Gosk about NIH’s research efforts to study “long-haul” COVID-19 patients
<a href="/news-events/nih-research-matters/sars-cov-2-antibodies-protect-reinfection">SARS-CoV-2 antibodies protect from reinfection</a>
<a href="/news-events/nih-research-matters/antibody-treatment-mers-coronavirus-safe-people">Antibody treatment for MERS coronavirus safe in people</a>
<a href="/news-events/nih-research-matters/poor-air-quality-across-northeastern-public-transit-systems">Poor air quality across Northeastern public transit systems</a>
Notice of Special Interest (NOSI) in Reducing Suicide Risk in Young People in Low- and Middle-Income Countries and Low-Resource Settings
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required)
Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required)
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01 Clinical Trial Required)
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder Epidemic
Notice of Special Interest: Advancing Health Communication Research on HIV Prevention, Treatment and Cure
Triadic Interactions in Clinical Encounters Involving People with Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD), Clinicians, and Care Partners (R01 Clinical Trial Optional)
Announcement of Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Supported Individual Fellows
NIH effort seeks to understand MIS-C, range of SARS-CoV-2 effects on children
Law enforcement seizures of methamphetamine and marijuana rose during pandemic
NIH halts trial of COVID-19 convalescent plasma in emergency department patients with mild symptoms
NIH invests in next iteration of public-private partnership to advance precision medicine research for Alzheimer’s disease
Notice of Special Interest (NOSI): Multi-Level HIV Prevention Interventions for Individuals at the Highest Risk of HIV Infection
Notice of Special Interest (NOSI): Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care
Notice of Special Interest (NOSI): Translation of BRAIN Initiative Technologies to the Marketplace
Notice of NIDDK Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)"
Notice of Technical Assistance Webinar for Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health
Notice of Special Interest (NOSI): Administrative Supplements for Research on Womens Health in the IDeA States
NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed)
2021 HHS Small Business Program Conference – April 26-30 – Save the Date!
NIH scientists discover how DNA fragments can trigger inflammation in sickle cell disease
Dr. Collins talks to CBN News’ Lorie Johnson about COVID-19 vaccines
NIH-Sponsored ACTIV-3 Clinical Trial Closes Enrollment into Two Sub-Studies
Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)
NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed)
Tropical Medicine Research Centers (U01 Clinical Trial Not Allowed)
Tropical Medicine Research Centers Coordinating Center (U01 Clinical Trial Not Allowed)
Firearm Injury and Mortality Prevention Research (R01Clinical Trial Optional)
Firearm Injury and Mortality Prevention Research (R21/R33 Clinical Trial Optional)
Notice of Special Interest (NOSI): Administrative Supplements and Urgent Competitive Revisions for NIH Grants to Add or Expand Research Focused on Maternal Health, Structural Racism and Discrimination, and COVID-19
In a Q&A with Government Executive, Dr. Collins discusses COVID-19 related topics, workforce morale during the pandemic, and the UNITE initiative
Notice of Change to Biosketch Instructions for PAR-20-066 "Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed)"
HEAL Initiative: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements to Support Strategies to Increase Participant Diversity, Inclusion and Engagement in Clinical Studies
CBS 60 Minutes’ Sharyn Alfonsi discusses drug repurposing with Dr. Collins
Notice of Correction to Application Types Allowed for RFA-TR-21-010 Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
Limited Competition to Convert the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) Study Cohort to a Research Resource (R24 - Clinical Trial Not Allowed)
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
CSR’s Commitment to Advancing Equity, Diversity and Inclusion in Peer Review
Statement on NIH starting enrollment for third trial of blood clotting treatments for COVID-19
Dr. Collins joins the Art of Excellence podcast to discuss a range of topics including his childhood, career, and NIH’s response to the COVID-19 pandemic
<a href="/news-events/nih-research-matters/cells-maintain-repair-liver-identified">Cells that maintain and repair the liver identified</a>
<a href="/news-events/nih-research-matters/most-covid-19-hospitalizations-due-four-conditions">Most COVID-19 hospitalizations due to four conditions</a>
<a href="/news-events/nih-research-matters/fruit-vegetable-consumption-reduce-risk-death">Fruit and vegetable consumption reduce risk of death</a>
Parenting in a Time of COVID
Drs. Collins and Fauci join Mary Louise Kelly on NPR All Things Considered to reflect on the year anniversary of the pandemic
NIH scientists use human cerebral organoid to test drug for deadly brain disease
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)
BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Using Systems Science Methodologies to Protect and Improve Child and Reproductive Population Health
Notice of Special Interest (NOSI): Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy
Notice of Special Interest (NOSI): NINR Priority Areas for Training and Career Development Awards
Request for Information (RFI): Invitation to Comment on the Draft NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Down Syndrome Research Plan
Study of mosquito protein could lead to treatments against life-threatening viruses
NIH researchers develop guidelines for reporting polygenic risk scores
Notice of NINR Participation in PA-18-935, "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement/Clinical Trial Optional)"
Request for Information (RFI): Improving the Mental Health of Rural People
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed)
HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
AHRQ/PCORI Learning Health System Small Grant Pilot Program
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
Notice of Early Expiration of NOT-MH-21-075 Notice of Special Interest (NOSI) regarding the Use of Human Connectome Data for Secondary Analysis
Notice of Special Interest (NOSI): Understanding and Addressing the Impact of Structural Racism and Discrimination on Biomedical Career Progression and the Biomedical Research Enterprise
Notice of NIAMS Participation in NOT-EB-21-001 "Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health"
On Yahoo Finance Live’s Influencers with Andy Serwer, Dr. Collins provides an update on COVID-19 vaccines and discusses what we may expect in the coming months
NIH-led team sets new bar in retinal imaging
NIH awards grants to support bacteriophage therapy research
Preterm birth, prolonged labor influenced by progesterone balance
Notice of Special Interest: Innovative Approaches or Technologies to Investigate Regional, Structural and Functional Heterogeneity of CNS Small Blood and Lymphatic Vessels in AD/ADRD
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Upcoming Changes to the Biographical Sketch and Other Support Format Page for Due Dates on or after May 25, 2021
Dr. Collins talks to MSNBC’s Ali Velshi about maintaining public health measures and continuing to wear a face covering even as more people are vaccinated
CBS News features Dr. Collins in a 60 Minutes segment taking an in-depth look at COVID-19 variants
Dr. Collins comments on “long-haul” patients still recovering from COVID-19
Notice of Correction to NOT-OD-21-065 "Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Required)" for Clinical Trial Requirements
Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed)
Notice of Special Interest: Impact of COVID-19 on Dementia Risk, Progression and Outcomes in ADRD Populations
Medical Scientist Training Program (T32)
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required)
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Not Allowed)
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Required)
Notice of NICHD Participation on PA-20-184 "Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)"
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required)
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required)
All About Grants Podcast: Diversity Plans for Conference Applications
Announcement of Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows
Notice of Correction to Application and Submission Information for NOSI: Availability of Administrative Supplements for Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows (NOT-OD-21-070)
<a href="/news-events/nih-research-matters/mitochondrial-dna-involved-sickle-cell-disease">Mitochondrial DNA involved in sickle cell disease </a>
<a href="/news-events/nih-research-matters/study-reveals-how-apoe4-gene-may-increase-risk-dementia">Study reveals how APOE4 gene may increase risk for dementia</a>
<a href="/news-events/nih-research-matters/drug-delays-type-1-diabetes-onset">Drug delays type 1 diabetes onset</a>
Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)
Request for Information (RFI): Ovarian Anatomy Nomenclature Workshop Proposal at NICHD
Notice of NICHD Participation in PA-20-183, "Research Project Grant (Parent R01 Clinical Trial Required)"
Notice of Information: NCATS to Issue an Emergency Competitive Revision Sole Source Award in Support of ACTIV-6
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required)
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed)
Dr. Collins participates in a vaccine confidence event at the Washington National Cathedral
Dr. Collins talks to Dr. John Whyte at WebMD to discuss a variety of topics around COVID-19, faith and science, and the new UNITE initiative
Dr. Collins joins MSNBC’s Katy Tur to discuss COVID-19 vaccinations, new variants, and continuing public health measures
Notice of Special Interest (NOSI): Hyperacute MRI Imaging Studies to Understand How Brain Changes Affect AD/ADRD-Relevant Trajectories and Outcomes Post-Stroke
Notice of Special Interest (NOSI): Administrative Supplements for Collaborative Activities to Promote Sleep/Circadian Research in ADRD
Notice of Special Interest (NOSI): Administrative Supplement for Genome-wide Genotyping of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data
Notice of Pre-Application Webinar and Frequently Asked Questions (FAQs) for NHLBI ENRICH RFA-HL-22-007 "Clinical Centers (UG3/UH3)" and RFA-HL-22-008 "Resource and Coordinating Center (U24)"
Notice of Information: NHLBI Extensions for Career Development Award (K01, K08, K23, K25) Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19
Notice of Change: Extension of PA-18-705 "SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)"
Top 3 Applicant and Grantee Systems Resources
Notice of Intent to Publish a Funding Opportunity Announcement for Neurosurgeon Research Career Development Program (NRCDP) (K12)
Webinar Available on Progress Towards Reducing Administrative Burden While Maintaining Animal Welfare and Scientific Integrity
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional)
Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)
Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed)
Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for the ARDS, Pneumonia, and Sepsis Phenotyping Consortium Clinical Centers (U01 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for the ARDS, Pneumonia, and Sepsis Phenotyping Consortium Coordinating Center (U01)
Research on Bat Immunology (R21 Clinical Trial Not Allowed)
Notice of Correction for PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional)
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional)
In an interview on Good Morning America, Dr. Collins addresses vaccine hesitancy
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
High-Priority Behavioral and Social Research Networks in Alzheimers Disease and Alzheimers Disease-Related Dementias (R24 Clinical Trial Optional)
High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional)
Notice of Change to Key Dates of RFA-MH-21-120, "Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional)"
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Notice of Change to Key Dates for NIDA RFA-DA-22-004, " Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)"
Notice of Special Interest (NOSI) to add harassment as an area of interest to Research to Understand and Inform Interventions that Promote the Research Careers of Individuals in the Biomedical Sciences
NIH statement on the departure of Dr. Christopher Austin
Dr. Collins co-authors a commentary in Cell on opportunities for precision medicine in the coming decade
NIH leaders on the future of precision medicine, healthcare transformation
Core Centers for Clinical Research (CCCR) (P30)- Clinical Trial Not Allowed
Notice of Special Interest (NOSI): Conferences and Scientific Meetings Aimed at Supporting the National Eye Institutes Audacious Goals Initiative
Notice of Informational Webinar on the NIGMS U-RISE and MARC Programs
Program to Advance the Career Development of Scientists from Diverse Backgrounds Conducting Nutrition, Obesity, Diabetes, and Related Research (U24 Clinical Trial Optional)
Dr. Collins and author Walter Isaacson join the MSNBC Morning Joe hosts to discuss the development of CRISPR gene-editing technology
How Do I Request Childcare Costs in my Fellowship Application?
Notice of Change to NOT-OD-20-024: Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
Notice of Change to NOT-OD-20-025: Notice of Special Interest (NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
Notice of NIH Participation in the National Robotics Initiative (NRI)
Notice of Correction for PAR-21-057 "Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
Notice of Correction to R and R Budget Form for PAR-21-160, NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Notice of Special Interest (NOSI): Fundamental Science Research on Complementary and Integrative Health Approaches
Notice of Special Interest (NOSI): Administrative Supplement for Providing Technical and Business Assistance (TABA) Funding to SBIR/STTR Awardees (Admin Supp)
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiative (Phase II)
Notice of Corrections to PAR-20-181, Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed)
Expansion of Eligibility: Technical and Business Assistance (TABA) Needs Assessment Program for National Institutes of Health (NIH) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees
Updated NHLBI Guidance Concerning Mentored Career Development (K08 and K23) Awards: Percent Effort
Recompetition of the Pediatric Scientist Development Program (PSDP) (K12 Clinical Trial Not Allowed)
Investigational AstraZeneca vaccine prevents COVID-19
Graduates of comprehensive preschool program less likely to be obese in adulthood, NIH-funded study finds
Notice of Clarification of Research Priorities for RFA-AA-21-002 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed) "
Notice of Clarification of Research Priorities for RFA-AA-21-003 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed) "
Notice of Change to Key Dates for RFA-NS-20-006 "BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional)"
Notice of Clarification of Research Priorities for RFA-AA-21-004 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)"
Continued Extension of Certain Flexibilities for Prospective Basic Experimental Studies With Human Participants
Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed)
Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
Notice of Special Interest (NOSI): Investigations on Inborn Errors of Immunity/Primary Immunodeficiencies
Notice of Early Expiration of PAR-19-347 "Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)"
Notice of Early Expiration of PAR-19-346 "Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)"
Notice of Change to Eligibility Information in RFA-AI-20-080, "Human Immunology Project Consortium (HIPC) Coordinating Center (U01 Clinical Trial Not Allowed)"
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)
NIAID Statement on AstraZeneca Vaccine
Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)
Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed)
Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed)
Updated Reporting Requirements for RADx-rad Grant Recipients
Notice of Special Interest (NOSI): Characterization of Genomics of Induced Pluripotent Stem Cell Lines for AD/ADRD Research
Notice of Special Interest (NOSI): Administrative Supplements for COVID-19-Impacted FIC Research Training and Education Awards
Notice of Special Interest (NOSI): Administrative Supplements to FIC Awards for COVID-19-related Research in Low- or Middle-Income Countries
African Americans who smoke seem at higher risk of coronary heart disease
Continued Extension of Policy Flexibilities for Basic Experimental Studies Involving Humans (BESH)
NIH, DC government form partnership to reduce sleep-related infant deaths
Updated Notice of Limited Availability of Research Non-Human Primates
Notice of Special Interest (NOSI): Basic Research on Fentanyl and Synthetic Fentanyl Analogs: Signaling, Neurobiology, and Pharmacology
Notice of Information: NIAAA Clinical Medications Development Testing Program
Understanding NRSA Fellowship “F” and Training “T” Grants: A Video Guide
Notice of Special Interest (NOSI): Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects
NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00)
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
Notice of NICHD Participation in PAR-20-266, "Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)"
Notice of NICHD Participation in PAR-21-099, "Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional)
Notice of NICHD Participation in PAR-21-100, "Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional)"
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
The Impact of the COVID-19 Pandemic on the Extramural Scientific Workforce – Outcomes from an NIH-Led Survey
Scientists find evidence that novel coronavirus infects the mouth’s cells
Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed)
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed)
NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Administrative Supplements for research on fentanyl and derivatives
Engineered immune cells deliver anticancer signal, prevent cancer from spreading
Moderate daily caffeine intake during pregnancy may lead to smaller birth size
DNA damage “hot spots” discovered within neurons
Notice of Change to AIDS Date of RFA-MH-21-120, "Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional)"
Notice of Special Interest (NOSI): Stimulate Research on the Diagnosis, Treatment, and Mechanistic Understanding of Postural Orthostatic Tachycardia Syndrome (POTS)
Notice of Pre-Application Information Webinar for PAR-21-092, "NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)"
Notice of Extension of Application Due Date for RFA-DK-20-034, "Program to Advance the Career Development of Scientists from Diverse Backgrounds Conducting Nutrition, Obesity, Diabetes, and Related Research (U24 Clinical Trial Optional)"
Dr. Collins and NASA Astronaut Dr. Kate Rubins discuss conducting scientific research in space
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research (Collaborative U01 Clinical Trial Optional)
Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth) Research Training (Collaborative U2R Clinical Trial Optional)
Request for Information: Challenges and Opportunities in Understanding Cellular Senescence and Senolytics
Notice of Intent to Publish a Funding Opportunity Announcement for PHS 2021 Omnibus Solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
Notice of Early Expiration of PA-19-068, Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Administrative Supplement for Genome-wide Genotyping of Existing Samples from Minority Racial/Ethnic Populations and Sharing of Associated Epidemiologic Data
Notice of Change: Change in Data Table Submission Requirements for PAR-21-120, Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
Nutrition Obesity Research Centers (P30 Clinical Trial Optional)
Notice of Change to Funding Opportunities for NOT-EB-20-017, "Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications"
Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Optional)
Dr. Collins debunks COVID-19 vaccine myths on The Bobby Bones Show
Notice of Special Interest (NOSI): Deciphering the Mosaic of Glia in the Addicted Brain
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)
Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: January 2022 Council
User-Based Design to Aid in Contraceptive Development by Small Business (R43 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Joint NINDS and NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
Updated Notice of Information: NHLBI Extensions for Career Development Award (K01, K08, K23, K25) Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19
Notice of Change in Advisory Council Review for RFA-MD-21-006 "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)"
Younger age of first cannabis use or prescription drug misuse is associated with faster development of substance use disorders
NIH to enhance tribal engagement efforts for precision medicine research
<a href="/news-events/nih-research-matters/measles-vaccine-used-base-experimental-covid-vaccine">Measles vaccine used as base for experimental COVID vaccine </a>
<a href="/news-events/nih-research-matters/gene-therapy-chronic-pain-relief">Gene therapy for chronic pain relief</a>
<a href="/news-events/nih-research-matters/fungi-may-impair-wound-healing-crohns-disease">Fungi may impair wound healing in Crohn’s disease </a>
Notice of Correction to NOT-OD-21-071 Administrative Supplements and Urgent Competitive Revisions for NIH Grants to Add or Expand Research Focuses on Maternal Health, Structural Racism and Discrimination, and COVID-19
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed)
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed)
Dr. Collins talks to Fox News’ Neil Cavuto about the COVID-19 vaccine rollout and vaccine hesitancy
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44)
Notice of NIGMS Funding Priorities for PAR-19-301 "Limited Competition: NIGMS National and Regional Resources (R24 Clinical Trial Not Allowed)"
Notice of Expansion of Research Scope of RFA-AI-21-004 "Tropical Medicine Research Centers (U01 Clinical Trial Not Allowed)
Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed)
Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional)
Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional)
Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional)
T cells recognize recent SARS-CoV-2 variants
Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)
Research on Autism Spectrum Disorders (R21 Clinical Trial Optional)
Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
Technologies to Advance Precision Medicine for Reproductive Health and Infertility (R43, R44 Clinical Trial Optional)
Notice of Special Interest (NOSI): Identification of Biomarkers of HIV Pathogenesis and Substance Use Disorder Comorbidity
Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed)
Notice of Change: Extension of PA-18-926, Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional)
Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional)
Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed)
Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)
Preventive treatment reduces diabetic retinopathy complications
NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): COVID-19 Related School Disruptions Impact on Mental Health, Cognitive, Social, and Emotional Development of Children
Notice of Intent to Publish a Funding Opportunity Announcement for New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional)
CDC and NIH bring COVID-19 self-testing to residents in two locales
Notice of Participation of NIMH in NOT-EY-21-001, "Notice of Special Interest (NOSI): National Research Service Award (NRSA) F32 Postdoctoral Fellowship Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities"
Notice of Change to Key Dates for NIDA PAR-21-208, " Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)"
Notice of Intent to Publish a Funding Opportunity Announcement: Early Detection Research Network (EDRN) Data Management and Coordinating Center
Notice of Intent to Publish a Funding Opportunity Announcement: Early Detection Research Network (EDRN) Clinical Validation Centers
Notice of Intent to Publish a Funding Opportunity Announcement for The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)
2021 NIAID Omnibus Broad Agency Announcement HHS-NIH-NIAID-BAA2021-1 Now Available
2021 HHS Small Business Program Conference: Diverse Perspectives SEEDing Impactful Innovations
NIH clinical trial evaluating Moderna COVID-19 variant vaccine begins
Short-Term Mentored Research Career Enhancement Award to Promote Diversity (K18 No Independent Clinical Trials)
Registration is Now Open for the 2021 HHS Small Business Program Conference on April 26-30!
Notice of Special Interest (NOSI) for Illuminating the Druggable Genome (IDG) Initiative: Request for Administrative Supplements to Existing Grants for incorporating single cell data into the IDG Knowledgebase
Notice of Special Interest: Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01, R21)
Notice of Change to Key Dates for NIDA PAR-21-183, " Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)"
Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed)
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required)
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Notice of Change to Expiration Date for OBSSR RFA-OD-21-005 "Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed)
Notice of Participation of the National Institute of Allergy and Infectious Diseases (NIAID) in PAR-21-109 Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
Reminders of NIH Policies Related to Closeout
In an interview for Fox News Radio’s podcast From Washington, Dr. Collins provides an update on COVID-19 vaccinations, public health measures, achieving herd immunity, and more
Notice of Intent to Publish the Reissuance of PAR-18-422, NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)
Notice of Intent to Publish the Reissuance of RFA-NS-18-020, BRAIN Initiative: Novel Technologies and Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
The National Institutes of Health (NIH) Sexual and Gender Minority Research Office Request for Nominations for 2021 SGM Research Investigator Awards Program
Notice of Intent to Publish the Reissuance of RFA-NS-18-019, BRAIN Initiative: Optimization of Transformative Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed)
Radiation-Induced Immune Dysfunction (U01 Clinical Trial Not Allowed)
Notice of Extension to PAR-18-894, "Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed)"
Notice of Correction to Key Dates of NOT-MH-21-105, Notice of Special Interest: Advancing Health Communication Research on HIV Prevention, Treatment and Cure
Notice of Clarification of Eligibility Regarding Foreign Components for PAR-19-257, "Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)"
Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed)
Dr. Collins shares a message of hope to end the suffering from the COVID-19 pandemic on CBS Sunday Morning
Specialized Alcohol Research Centers (P50 Clinical Trial Optional)
Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)
BRAIN Initiative: Targeted BRAIN Circuits Planning Projects TargetedBCPP (R34 Clinical Trials Not Allowed)
NINDS Program Project Grant (P01 Clinical Trial Optional)
Proteome Characterization Centers (PCCs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed)
Proteogenomic Data Analysis Centers (PGDACs) for Clinical Proteomic Tumor Analysis Consortium (U24 Clinical Trial Not Allowed)
Proteogenomic Translational Research Centers (PTRCs) for Clinical Proteomic Tumor Analysis Consortium (U01 Clinical Trial Not Allowed)
Notice of Special Interest: Support for existing data repositories to align with FAIR and TRUST principles and evaluate usage, utility, and impact
Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science
Notice of Intent to Publish the Reissuance of PAR-18-420, NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required)
Notice of Addition of Clinical Research Operations and Management System (CROMS) Language in PAR-20-309 Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
Change to NINDS Administrative Reduction Policy for Modular R01 Awards
NIH Blueprint for Neuroscience Research: Request for Information (RFI) on Neuroimmune Interactions in the Healthy CNS
Notice of Special Interest (NOSI): Availability of Administrative Supplements for the Network of the National Library of Medicine (NNLM) Center for Data Science and Delivery of Data Services.
Limited Competition: Revision to the Longitudinal Monitoring of Pancreas Architecture in the Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional)
Research Experiences to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed)
NIH scientists develop breath test for methylmalonic acidemia
Explore Our New Extramural Nexus Site and Subscription Options
<a href="/news-events/nih-research-matters/drug-prescriptions-older-adults-dementia">Drug prescriptions in older adults with dementia</a>
<a href="/news-events/nih-research-matters/nanoparticle-based-flu-vaccine">Nanoparticle-based flu vaccine</a>
<a href="/news-events/nih-research-matters/sars-cov-2-may-infect-mouth-cells">SARS-CoV-2 may infect mouth cells</a>
Reminder: NIH Will Continue to Accept Preliminary Data as Post-Submission Material Through January 2022 Council
Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being
Community Engaged Research on Pregnancy Related and Associated Infections and Sepsis Morbidity and Mortality (UG3/UH3 Clinical Trial Optional)
Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trial Required)
Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional)
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed)
Notice of Participation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in PA-21-110 Pilot and Feasibility Studies in Preparation for Substance Use Preventions Trials (R34 Clinical Trial Optional)
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
Understanding HIV Reservoir Dynamics (P01, Clinical Trial Not Allowed)
Limited Interaction Targeted Epidemiology (LITE-2): To Advance HIV Prevention (UG3/UH3 Clinical Trial Optional)
Dr. Collins joins Fox Houston’s the Isiah Factor Uncensored to discuss overcoming vaccine hesitancy to reach herd immunity
NIH begins study of allergic reactions to Moderna, Pfizer-BioNTech COVID-19 vaccines
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R43/R44 - Clinical Trial Not Allowed)
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R41/R42 - Clinical Trial Not Allowed)
Centers on Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required)
Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health
NIH-funded research team develops language test for people with Down syndrome
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for NIH Bridge2AI Integration, Dissemination, and Evaluation (BRIDGE) Center (U54 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Research Opportunity Announcement for the Data Generation Projects of the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (OT2)
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required)
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32)
NIH experts call for accelerated research to address concurrent HIV and COVID-19 pandemics
Notice to Extend the Response Date for NOT-OD-21-066, "Request for Information (RFI): Inviting Comments and Suggestions to Advance and Strengthen Racial Equity, Diversity, and Inclusion in the Biomedical Research Workforce and Advance Health Disparities a
How Are Schools and Departments Assigned to NIH Grants?
Notice of Information Reissuance of PAR-18-307, "Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional), as a Notice of Special Interest (NOT-OD-21-087)
Notice of Information Reissuance of PAR-18-324, "Testing Interventions for Health-Enhancing Physical Activity (R01-Clinical Trial Optional)" as a Notice of Special Interest (NOT-OD-21-087)
HEAL Initiative: Notice of Special Interest (NOSI): Limited Competition to Support Mentorship of Junior Investigators
Dr. Collins participates in a virtual event with Biologos on how Christians can help end the COVID-19 pandemic
The NIH SABV Policy: E-learning Opportunities and a Symposium Provide Guidance and Inspiration
Notice of Pre-Application Webinar for Funding Opportunities on Transformative Research to Address Health Disparities and Advance Health Equity
Notice of Special Interest (NOSI): Administrative Supplements for Workforce Development at the Interface of Information Sciences, Artificial Intelligence and Machine Learning (AI/ML), and Biomedical Sciences
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)
Drug testing approach uncovers effective combination for treating small cell lung cancer
<a href="/news-events/nih-research-matters/how-stress-causes-hair-loss">How stress causes hair loss </a>
<a href="/news-events/nih-research-matters/sweat-sticker-diagnosing-cystic-fibrosis">“Sweat sticker” for diagnosing cystic fibrosis</a>
<a href="/news-events/nih-research-matters/immune-response-vaccination-after-covid-19">Immune response to vaccination after COVID-19</a>
Population Dynamics Centers Research Infrastructure Program FY 2022 (P2C Clinical Trial Not Allowed)
Request for Information (RFI): Research Challenges and Needs in Developing Chronomedicine for Health and Diseases
Emergency Awards: Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (U01 Clinical Trial Optional)
Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional)
Notice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake
Emergency Award: RADx-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trials Optional)
DEADLINE EXTENDED: Submit Your Feedback on NIH UNITE by April 23
Study links structural brain changes to behavioral problems in children who snore
Notice of Clarification of Resubmission Due dates for RFA-RM-21-012, Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2022 (R24 Clinical Trial Not Allowed)
Notice of Addition of Requested Institutional Information for RFA-RM-21-022 - Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions
Notice of Intent to Publish a Funding Opportunity Announcement for Non-Human Primate Developmental Genotype-Tissue Expression (NHP dGTEx) Project (U24 Clinical Trials Not Allowed)
Updated NCI Guidance Concerning the Mentored Clinical Scientist Research Career Development Award: Percent Effort of Surgeon-Scientists for K08 awards from NCI
NIH experts discuss post-acute COVID-19
NIH trial of anti-CD14 antibody to treat COVID-19 respiratory disease begins
Notice of Special Interest (NOSI): Topic Areas for PAR-21-203, Limited Competition: Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed)
Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-002 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed)"
Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-003 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed)"
Notice of Change: Extension and Additional Key Dates for NIAAA RFA-AA-21-004 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)"
3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)
Notice of NIAAA Participation in NOT-OD-21-086 "Notice of Intent to Reissue PAR-18-324 "Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)" as a Notice of Special Interest (NOSI)"
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Administrative Core (U24) (Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Diagnostic-Telemedicine Core (U24 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Data Coordination Core (U24 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional)
Reminder: Required use of FORMS-F application forms for application submission
Most differences in DNA binding compounds found at birth in children conceived by IVF not seen in early childhood
Notice of Change: Receipt date added for RFA-EB-20-002, "BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required)
NIMHD Multiple Chronic Disease Disparities Research Coordinating Center (RCC) (U24 Clinical Trial Not Allowed)
New Reviewer Resources for Assessing the Vertebrate Animals Section
Notice of Special Interest (NOSI): Telehealth in Cancer Care
Notice of Special Interest (NOSI): Administrative Supplement for Modifiable Factors Potentially affecting the Cost of Cancer Treatment
NIH funds new influenza research network
Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
Notice of Special Interest (NOSI) Announcing the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
Enhancing NIDCD's Extramural Workforce Diversity through Research Experiences (R25 Clinical Trial Not Allowed)
Notice of NIAAA Participation in NOT-OD-21-087 "Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being"
Biomarker Research to Support Fertility Regulation Development by Small Business (R43 Clinical Trial Optional)
Notice of NIAAA Participation in NOT-OD-21-085 "Notice of Intent to Reissue PAR-18-307 " Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)" as a Notice of Special Interest (NOSI)"
NIH closes enrollment in trial comparing COVID-19 treatment regimens
Dr. Collins addresses vaccine hesitancy in an interview with Fox News’ Neil Cavuto
NIH-funded COVID-19 testing initiative aims to safely return children to in-person school
Identification of Positive Valence System Related Targets for Novel Suicide Prevention Approaches (R21 Clinical Trial Optional)
Identification of Positive Valence System Related Targets for Novel Suicide Prevention Approaches (R01 - Clinical Trial Optional)
Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations to Improve the AI/ML-Readiness of NIH-Supported Data
Notice of Correction for RFA-LM-21-001, "NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed)"
Notice of NCI's Participation in PAR-21-169, "Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)"
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Black Children and Adolescents (R01 Clinical Trial Optional)
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Black Children and Adolescents (R34 Clinical Trial Optional)
Updated Guidance Regarding Administration of the NCI Outstanding Investigator Award (R35) Program
Notice of Pre-Application Webinar for Companion Announcements PAR-21-207 and RFA-AG-22-016 Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/A
Notice of Special Interest (NOSI): Research on Strategies to Enhance Mental Health Interventions and Services within Employment and Job Training Settings
Update on Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research
Notice of Pre-Application Webinar for Hubs of Interdisciplinary Research and Training in Global Environmental and Occupational Health (GEOHealth), RFA-TW-21-001 (U01 Clinical Trial Optional) and RFA-TW-21-002 (U2R Clinical Trial Optional)
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional)
Systems-Level Risk Detection and Interventions to Reduce Suicide, Ideation, and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional)
Building Interdisciplinary Research Careers in Women's Health Program (BIRCWH) (K12 Clinical Trial Optional)
Notice of Special Interest (NOSI): Research Supplements to Promote Diversity in Environmental influences on Child Health Outcomes (ECHO) Program Research (Admin Supp - Clinical Trial Not Allowed)
Experimental antiviral for COVID-19 effective in hamster study
Pilot Effectiveness Trials of Interventions for Preschoolers with ADHD (R34 Clinical Trial Required)
AHRQ Notice of Extension of PA-21-202
Developmental Mechanisms of Human Structural Birth Defects (P01 Clinical Trial Not Allowed)
NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award (R21 Clinical Trial Not Allowed)
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
Why Properly Acknowledging NIH Support in Your Paper is Important
<a href="/news-events/nih-research-matters/study-finds-link-between-red-hair-pain-threshold">Study finds link between red hair and pain threshold</a>
<a href="/news-events/nih-research-matters/tracking-hallucinations-mice">Tracking hallucinations in mice</a>
<a href="/news-events/nih-research-matters/supplement-targets-gut-microbes-boost-growth-malnourished-children">Supplement targets gut microbes to boost growth in malnourished children</a>
Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed)
Publication of the Revised NIH Grants Policy Statement (Rev. April 2021) for Fiscal Year 2021
Expanding Requirement for eRA Commons IDs to All Senior/Key Personnel
Notice of Requirement for Submission of Current and Pending Support Information in PAR-19-313 Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional)
Notice of Requirement for Submission of Current and Pending Support Information for the PD(s)/PI(s) of PAR-20-115 Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase 3 - Transitional Centers (P30)"
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24)
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24)
Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01)
NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed)
Notice of Requirement for Submission of Current and Pending Support Information in PAR-19-312 Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 Clinical Trial Optional)
NICHD Small Research Grant Program (R03 Clinical Trial Required)
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
Notice of Change to NOT-OD-21-087, Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being
FY 2020 By the Numbers: Extramural Investments in Research
Notice of Change to PAR-20-214, "Research to Improve Native American Health (R21 Clinical Trials Optional)"
Notice of Intent to Publish a Funding Opportunity Announcement for Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions (TBEL) (U24 Clinical Trial Not Allowed)
Notice of Change to PAR-20-238, "Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)"
Notice of NIAMS Participation in PAR-19-343, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)"
Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed)
Large NIH clinical trial will test polyclonal antibody therapeutic for COVID-19
Request for information (RFI) on enhancing the science for the Environmental influences on Child Health Outcomes (ECHO) program
Dr. Collins joins MSNBC’s Meet the Press Daily to discuss vaccine hesitancy and achieving herd immunity
The Use of Internet Explorer for eRA Modules is Coming to an End July 19
Request for Information (RFI): Seeking Stakeholder Input on Enhancing Cancer Health Disparities Research
Notice of Pre-Application Webinar for Phase II of the RADxSM-UP Initiative
Clinical trial of therapeutics for severely ill hospitalized COVID-19 patients begins
Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed)
Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed)
Kidney Precision Medicine Project Kidney Tissue Atlas Coordinating Center (U01 Clinical Trial Not Allowed)
Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Administrative Supplements to Promote Diversity for NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees
Medical records analysis links cannabis use disorder in pregnancy to infant health problems
International research teams explore genetic effects of Chernobyl radiation
Notice of Early Termination of PAR-21-162, Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Continuation of Temporary Extension of Applicant Eligibility in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)
Notice of Early Termination of PAR-21-152, NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed).
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for Administrative Supplements to Support Career Enhancement Related to Clinical Research on Pain (Admin Supp Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Availability of Funds to defray Childcare Costs for NCI, NIA, NIDCR, NIDDK, and NIH Blueprint Predoctoral to Postdoctoral Fellow Transition Programs F99 Awardees
Notice of Special Interest (NOSI): Administrative Supplements to Stimulate and Strengthen Global Cancer Survivorship Research
Notice of Intent to Reissue PAR-18-847 Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01- Clinical Trial Optional) and PAR-18-848 (R21 - Clinical Trial Optional) as a Notice of Special Interest (NOSI)
Notice of Special Interest (NOSI): Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence
Notice of Pre-Application Technical Assistance Webinar for RFA-MD-21-004, Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional)
Notice of Pre-Application Technical Assistance Webinar for RFA-AT-21-006, "Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)"
NIDCR Policy on Applications for Investigator-Initiated Clinical Trials
Pre-Application Webinar for the Clinical Proteomic Tumor Analysis Consortium (CPTAC): RFA-CA-21-023 (U24), RFA-CA-21-024 (U24), and RFA-CA-21-025 (U01)
Notice of Additional Information for PAR-20-101, Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)
Notice of Intent to Reissue PAR-18-845 Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) and PAR-18-846 (R21 - Clinical Trial Not Allowed) as a Notice of Special Interest (NOSI)
Continuation of Temporary Extension of Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) During the COVID-19 Pandemic
Find a Fit for Your Research at NIH
All Senior/Key Personnel Required to Have A Commons ID Listed on Applications for Due Dates on Or After January 25, 2022
COVID-19 vaccine responses to be studied in people with immune deficits
NIH establishes new childhood asthma clinical research network
Dr. Collins joins Good Morning America with George Stephanopoulos for a discussion focused on COVID-19 vaccines
On Meet the Press, Dr. Collins talks about the J&J vaccine and benefits of vaccination outweighing the risks
Pre-application Webinar for RFA-CA-21-029, Centers for Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required)
CBS This Morning features CDC and NIH’s self-testing initiative which provides a month-long supply of rapid tests to residents in two locales in North Carolina and Tennessee
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
Notice of Extension of the Expiration Date of PAR-19-159, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)"
Guidance Regarding Reduction of Effort for Surgeons on NIA Individual Mentored K Awards
Prototype app for mobile devices could screen children at risk for autism spectrum disorder
<a href="/news-events/nih-research-matters/oral-antiviral-drug-effective-against-covid-19-hamsters">Oral antiviral drug effective against COVID-19 in hamsters</a>
<a href="/news-events/nih-research-matters/targeted-treatments-small-cell-lung-cancer">Targeted treatments for small-cell lung cancer</a>
<a href="/news-events/nih-research-matters/lack-sleep-middle-age-may-increase-dementia-risk">Lack of sleep in middle age may increase dementia risk</a>
Notice of NICHD Participation in RFA-AI-20-077 Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)
Notice of Modification for RFA-MD-21-007, Centers for Multiple Chronic Diseases Associated with Health Disparities: Prevention, Treatment, and Management (P50 Clinical Trial Required)
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed)
Reminder of NIH Closeout Policies
Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Specialized Collaboratory on Human, Non-human Primate, and Mouse Brain Cell Atlases (U01 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) (U24 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative Cell Atlas Network (BICAN): Comprehensive Center on Human and Non-human Primate Brain Cell Atlases (UM1 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth
Notice of Special Interest (NOSI): Reproductive Health, Pregnancy, and Parenting among Women with Disabilities
Notice of Special Interest: National Cancer Institute Administrative Supplement Opportunity for Strategies to Optimize Recruitment and Retention of Cancer Prevention and Symptom Management Clinical Trial Participants
Helping To Protect the Privacy of Participants in Non-NIH Funded Research
Request for Information: Response to Proposed NIH Sleep Disorders Research Plan Critical Opportunities and Strategic Goals
Systems Approach to Understand Mechanisms of Heterogeneous Response to Influenza (R01 Clinical Trial Not Allowed)
Notice to Extend PA-18-794
Notice to Extend PA-18-795
Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional)
Notice of Special Interest (NOSI): Expanding Cancer Control Research in Persistent Poverty Areas
Trial of existing antibiotic for treating Staphylococcus aureus bacteremia begins
Translational Neural Devices (UG3/UH3 - Clinical Trial Optional)
Translational Neural Devices (U44 Clinical Trial Optional)
Notice of Change: Extension for PAR-18-820, "Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)"
Implementation of Changes to the Biographical Sketch and Other Support Format Page
Dr. Collins speaks to Washington Post’s Ariana Cha about the importance of testing and CDC and NIH’s self-testing initiative
Notice of Intent to Publish a Funding Opportunity Announcement for Acquired Resistance to Therapy Network (ARTNet) (U54 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet) (U24 Clinical Trial Not Allowed)
Resources for Basic Experimental Studies Involving Humans (BESH)
Notice of Information: Change in NCATS Prior Approval Process for New CTSA Program Pilot Projects and KL2 Projects that Involve Human Subjects Research
Notice of Change in Key Dates for RFA-AI-20-078, Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)
Testimony on The Long Haul: Forging a Path Through the Lingering Effects of COVID-19
Brain’s waste removal system may offer path to better outcomes in Alzheimer’s therapy
Cancer-linked mutation accelerates growth of abnormal stroke-causing brain blood vessels
NIDDK Short-Term Research Experience Program to Unlock Potential (STEP-UP) (R25 Clinical Trial Not Allowed)
Temporary Extension of Eligibility for the NINDS F32 Award Due the COVID-19 Pandemic
Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Advance Health Equity
What Are the Requirements for Reporting on Human Study Participant Age, Sex/Gender, and Race/Ethnicity?
Addressing Social Determinants of Health to Eliminate Oral Health Disparities (UG3/UH3 Clinical Trials Optional)
NIH to invest $29 million to address COVID-19 disparities
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Leveraging Longitudinal Studies in Animal Models to Identify Neural Mechanisms of Vulnerability and Resilience to Substance Use Disorder
Notice of Special Interest (NOSI): Leveraging transformative connectome resources in model organisms to elucidate the neurobiology of substance use disorders
May 31 (Monday), 2021: NIH Closed for the Federal Holiday
Dr. Collins joins the Black Health Trust Sunday Program to discuss disparities and inequities in health care and COVID-19 topics
Request for Information (RFI): Drinking Water Contaminants of Emerging Concern for National Emerging Contaminant Research Initiative
Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required)
Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed)
Notice of NIBIB Participation in PAR-21-166 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)"
Notice of Special Interest (NOSI): NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities
Notice of NICHD Participation in RFA-AI-20-078 "Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)"
Scientists identify small-molecule cocktail to improve stem cell use in research and disease treatments
Researchers wirelessly record human brain activity during normal life activities
<a href="/news-events/nih-research-matters/uncovering-origins-brown-fat">Uncovering the origins of brown fat</a>
<a href="/news-events/nih-research-matters/boosting-brains-waste-removal-system-could-improve-alzheimers-outcomes">Boosting brain’s waste removal system could improve Alzheimer’s outcomes</a>
<a href="/news-events/nih-research-matters/genetic-effects-chernobyl-radiation-exposure">The genetic effects of Chernobyl radiation exposure</a>
Notice of Correction of Key Dates for PAR-20-284, Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)
Notice of NIBIB Participation to PA-20-194 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)"
Notice of Change to NOT-EB-21-005 "NIBIB Guidance for Support of Clinical Trial Applications"
Notice of Change in Key Dates for RFA-AI-20-077, Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)
Notice of Early Termination of PAR-21-159, Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C
Notice of Change to Additional Information for NOT-OD-21-094 "Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations to Improve the AI/ML-Readiness of NIH-Supported Data"
Notice of NIBIB Participation to PA-20-195 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)"
8th Annual 3Rs Symposium: Pandemic-Driven Advances June 3-4, 2021 | Virtual
NeuroNEXT Clinical Trials (U01 Clinical Trial Optional)
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Early-life Factors and Cancer Development Later in Life
Revised NIH Grants Policy Statement for FY 2021
Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
On Good Morning America Dr. Collins comments on overcoming vaccine hesitancy and expanding vaccine eligibility to adolescents
Dr. Collins and Fox News’ Martha MacCallum discuss the variant and spike of COVID-19 cases in India
Notice of Intent to Publish a Funding Opportunity Announcement for Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 - Clinical Trial Not Allowed)
Notice of Intent to Publish: Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 - Clinical Trial Not Allowed)
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)
Notice of Special Interest: Public Policy Effects on Alcohol-, Cannabis-, Tobacco-, and Other Drug-Related Behaviors and Outcomes
Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
Be the First to Know When We Post a New Nexus Post or Blog
Human Milk as a Biological System (R01 Clinical Trial Optional)
NIH Statement on World Asthma Day 2021
Updated Biographical Sketch and Other Support Format Pages Available Now and Required January 2022
Notice of NIDA's participation in NOT-NS-21-049, "Notice of Special Interest (NOSI): NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities"
Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed)
Research Program Award (R35 Clinical Trial Optional)
Notice of Special Interest (NOSI): Biology of Lung and Head and Neck Preneoplasia
NIAID Funded Extensions for Career Award Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19
NIAID Funded Extensions for Fellowship Award Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19
Notice of Pre-Application Webinar for RFA-CA-21-031, Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO; U01 Clinical Trial Required) and RFA-CA-21-032, (ENICTO Coordinating Center; U24 Clinical Trial Not Allowed)
On the Hugh Hewitt radio show, Dr. Collins discusses the pause on the J&J vaccine and other COVID news
Notice of Requirement for Submission of Current and Pending Support Information for the PD(s)/PI(s) of PAR-20-175 Institutional Development Award (IDeA) Networks for Clinical and Translational Research (IDeA-CTR) (U54 Clinical Trial Optional)"
Request for Information (RFI) on Flexibilities to Reduce Administrative Burden While Continuing to Apply the PHS Policy to Zebrafish Immediately After Hatching
Consortium for Innovative HIV/AIDS Vaccine and Cure Research (UM1 Clinical Trial Not Allowed)
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
Notice of Technical Assistance Webinar for NOT-OD-21-087, Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being NOSI
Notice to Include AIDS Receipt Dates in PAR-21-109 "Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)"
NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)
Notice of Correction to Eligibility Information of RFA-MH-21-180, "BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access and Manipulation to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed)"
Notice of Clarification of Eligibility of Applicant Organizations for RFA-HD-22-013: Population Dynamics Centers Research Infrastructure Program FY 2022 (P2C Clinical Trial Not Allowed)
Standardization of C-Peptide and HbA1C Measurements Program (U01 Clinical Trial Not Allowed)
Dr. Collins is a guest on the Fox News Radio podcast From Washington to talk about COVID-19 vaccines
Notice of Information: Establishment of a Standard THC Unit to be used in Research
NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required)
New ultrasound technique detects fetal circulation problems in placenta
Notice of Change to the Eligibility Information for RFA-DA-22-001, "Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional)"
In an interview with Agri-Pulse, Dr. Collins encourages vaccination in rural communities
Dr. Collins joins Good Morning America Weekend to discuss the COVID-19 virus surge in India and the current vaccine progress in the United States
Dr. Collins speaks to MSNBC’s Ali Velshi about CDC guidance on mask wearing and getting vaccinated after infection
Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required)
Notice of NIDCD Withdrawal from Participation in PA-20-184, "Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
Notice of Special Interest (NOSI): Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Continued Need for Documenting COVID-19-Related Patient Outcomes
Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
Enhancing Data Access and Analysis in the Cloud Advances NIH-Supported Discovery
Notice of Special Interest (NOSI): Administrative Supplements to Enhance Data Science Capacity at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)
Notice to Extend the Response Date for NOT-LM-21-005, "Request for Information (RFI): Use of Common Data Elements (CDEs) in NIH-funded Research"
Notice of Correction to the Application and Submission Instructions for the Pilot and Feasibility Program for RFA-DK-21-015, Nutrition Obesity Research Centers (P30 Clinical Trial Optional)
Long-lasting medications may improve treatment satisfaction in people with opioid use disorder
<a href="/news-events/nih-research-matters/app-may-help-identify-children-autism-spectrum-disorder">App may help identify children with autism spectrum disorder</a>
<a href="/news-events/nih-research-matters/biosensor-advances-drug-discovery">Biosensor advances drug discovery</a>
<a href="/news-events/nih-research-matters/supplement-improves-glucose-metabolism-womens-muscle">Supplement improves glucose metabolism in women’s muscle</a>
Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed)
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
Request for Information (RFI): Facilitating the Early Diagnosis and Equitable Delivery of Gene-Targeted Therapies to Individuals with Rare Diseases
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)
Notice of NIAAA's participation in NOT-NS-21-049, "Notice of Special Interest (NOSI): NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities"
SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
Gene therapy restores immune function in children with rare immunodeficiency
Availability of Frequently Asked Questions (FAQs) for RFA-HL-22-007 and RFA-HL-22-008: Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) program
NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-006 Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Independent Clinical Trial Not Allowed)
Notice of Change to Eligibility Information for RFA-AA-20-013 "Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional)
Request for Information (RFI): Seeking Stakeholder Input on Enhancing Diversity and Inclusion in the Cancer Research Workforce
Notice of Termination of NIEHS Participation on NOT-EB-21-012, Notice of Extension of the Expiration Date of PAR-19-159, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)"
Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (DRCC) (U24 Clinical Trial Not Allowed)

About Us

The Population Aging Research Center (PARC) at the University of Pennsylvania has over 25 years of experience of creating the right setting for interdisciplinary research on the demography and economics of aging, including a focus on diverse and often underrepresented populations domestically and globally. The Population Aging Research Center (PARC) was established in 1994 with a grant from the National Institute on Aging. PARC sponsors an annual pilot proposal competition, a weekly seminar series in conjunction with the Population Studies Center, the Penn Population Studies Colloquium and an online working paper series, the Population Center Working Papers (PSC/PARC). The overall research themes of PARC reflect the interests and expertise of our research associates. These include: Health Care and Long-Term Care in Older Adults, Cognition and Alzheimer's Disease and Related Dementia (ADRD), Health Disparities in Aging, Early Life-Conditions and Older Adult Health, Behavior and Well-Being, and Global Aging and Health.

Quick Links

IRB & Human Subjects
NIH Public Access Policy
PSC Library Catalog
Sociology Department
Economics Department
DONATE TO THE PSC

Request Services

Reserve the PSC Conference Room and/or Collaboration Space
Submit a Working Paper/Brief
Submit News & Events

About Us

The Population Aging Research Center (PARC) at the University of Pennsylvania has over 25 years of experience of creating the right setting for interdisciplinary research on the demography and economics of aging, including a focus on diverse and often underrepresented populations domestically and globally. The Population Aging Research Center (PARC) was established in 1994 with a grant from the National Institute on Aging. PARC sponsors an annual pilot proposal competition, a weekly seminar series in conjunction with the Population Studies Center, the Penn Population Studies Colloquium and an online working paper series, the Population Center Working Papers (PSC/PARC). The overall research themes of PARC reflect the interests and expertise of our research associates. These include: Health Care and Long-Term Care in Older Adults, Cognition and Alzheimer's Disease and Related Dementia (ADRD), Health Disparities in Aging, Early Life-Conditions and Older Adult Health, Behavior and Well-Being, and Global Aging and Health.

Contact

Tel: 215-898-6441
Fax: 215-898-2124

239 McNeil Building
3718 Locust Walk
Philadelphia, PA 19104-6298
[Map & Directions]

twitter.com/pennparc

facebook.com/pennpsc

Penn A-Z - Penn Calendar

© 2022 The Trustees of the University of Pennsylvania

Population Aging Research Center